TKT and glioblastoma: Gene therapy approaches were also well-represented, with researchers exploring the use of MSC-HSV-TK, which induces tumor cell death through a suicide gene system, and MSC tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), where MSCs delivered apoptosis-inducing ligands to GBM cells.